Glaxosmithkline News
- All
- News
-
Eye On Investment, Telangana Minister KTR Meets UK Healthcare Giant
Telangana Minister KT Rama Rao on Thursday held a meeting with Global R&D Head GSK Consumer Health, Franck Riot and discussed the expansion plans of GlaxoSmithKline, a healthcare company, for the state.
-
CCI Okays Acquisition Of 100% Shares In GlaxoSmithKline Asia By Parent Group Entities
CCI has okayed the acquisition of GlaxoSmithKline Asia Private Limited shareholding by parent group companies
-
Unilever Shows Interest In GSK's Consumer Health Business
Dove soap maker Unilever signalled on Monday it would pursue a deal for GlaxoSmithKline's consumer health business
-
GSK Sells Anesthetics To Aspen For Up To $370 Million
GlaxoSmithKline is to sell its portfolio of anesthetic drugs to South Africa's Aspen Pharmacare for up to 280 million pounds ($372 million) as part of a drive by the British drugmaker to focus on core therapy areas.
-
UK Drugs Giant GSK Invests 275 Million Pounds Despite Brexit
Drugmaker GlaxoSmithKline on Wednesday revealed plans to invest 275 million pounds into three of its British manufacturing sites, shrugging off Brexit worries.
-
GSK Consumer Suspends Punjab Plant Operations
GlaxoSmithKline Consumer Healthcare said that it took the step "in the interest of safety and security of its employees and to protect the assets of the factory."
-
GlaxoSmithKline CEO Witty to Retire in March 2017
GlaxoSmithKline said on Thursday its Chief Executive Andrew Witty would retire in 12 months time, after leading the group since 2008, prompting Britain's biggest drugmaker to start a formal search for his successor.
-
Novartis Okays OTC Unit Sale to GSK Consumer
The move follows a global deal struck in April last year, under which Swiss-based Novartis AG had agreed with UK-based GlaxoSmithKline plc to create a global consumer healthcare joint venture, GlaxoSmithKline Consumer Private Ltd (GSK CPL), as part of its global portfolio transformation.
-
Chinese Police Charge Former GSK China Head With Bribery
Mark Reilly, former head of China operations, and two other executives, Zhang Guowei and Zhao Hongyan, were also suspected of bribing officials in the industry and commerce departments of Beijing and Shanghai, Xinhua said.
-
GlaxoSmithKline India hit by drop in bulk orders: report
It did not give a further explanation in a statement and a Mumbai-based spokeswoman for the Indian unit of the UK-based pharmaceuticals company declined to elaborate.
-
China arrests two foreign fraud investigators: diplomats
China has formally arrested a foreign husband-and-wife team of fraud investigators, diplomats said Thursday, whose firm did work for British pharmaceutical giant GlaxoSmithKline which is facing a bribery probe.
-
Eye On Investment, Telangana Minister KTR Meets UK Healthcare Giant
Telangana Minister KT Rama Rao on Thursday held a meeting with Global R&D Head GSK Consumer Health, Franck Riot and discussed the expansion plans of GlaxoSmithKline, a healthcare company, for the state.
-
CCI Okays Acquisition Of 100% Shares In GlaxoSmithKline Asia By Parent Group Entities
CCI has okayed the acquisition of GlaxoSmithKline Asia Private Limited shareholding by parent group companies
-
Unilever Shows Interest In GSK's Consumer Health Business
Dove soap maker Unilever signalled on Monday it would pursue a deal for GlaxoSmithKline's consumer health business
-
GSK Sells Anesthetics To Aspen For Up To $370 Million
GlaxoSmithKline is to sell its portfolio of anesthetic drugs to South Africa's Aspen Pharmacare for up to 280 million pounds ($372 million) as part of a drive by the British drugmaker to focus on core therapy areas.
-
UK Drugs Giant GSK Invests 275 Million Pounds Despite Brexit
Drugmaker GlaxoSmithKline on Wednesday revealed plans to invest 275 million pounds into three of its British manufacturing sites, shrugging off Brexit worries.
-
GSK Consumer Suspends Punjab Plant Operations
GlaxoSmithKline Consumer Healthcare said that it took the step "in the interest of safety and security of its employees and to protect the assets of the factory."
-
GlaxoSmithKline CEO Witty to Retire in March 2017
GlaxoSmithKline said on Thursday its Chief Executive Andrew Witty would retire in 12 months time, after leading the group since 2008, prompting Britain's biggest drugmaker to start a formal search for his successor.
-
Novartis Okays OTC Unit Sale to GSK Consumer
The move follows a global deal struck in April last year, under which Swiss-based Novartis AG had agreed with UK-based GlaxoSmithKline plc to create a global consumer healthcare joint venture, GlaxoSmithKline Consumer Private Ltd (GSK CPL), as part of its global portfolio transformation.
-
Chinese Police Charge Former GSK China Head With Bribery
Mark Reilly, former head of China operations, and two other executives, Zhang Guowei and Zhao Hongyan, were also suspected of bribing officials in the industry and commerce departments of Beijing and Shanghai, Xinhua said.
-
GlaxoSmithKline India hit by drop in bulk orders: report
It did not give a further explanation in a statement and a Mumbai-based spokeswoman for the Indian unit of the UK-based pharmaceuticals company declined to elaborate.
-
China arrests two foreign fraud investigators: diplomats
China has formally arrested a foreign husband-and-wife team of fraud investigators, diplomats said Thursday, whose firm did work for British pharmaceutical giant GlaxoSmithKline which is facing a bribery probe.
